DK0792165T3 - Immunogene præparater - Google Patents

Immunogene præparater

Info

Publication number
DK0792165T3
DK0792165T3 DK95936690T DK95936690T DK0792165T3 DK 0792165 T3 DK0792165 T3 DK 0792165T3 DK 95936690 T DK95936690 T DK 95936690T DK 95936690 T DK95936690 T DK 95936690T DK 0792165 T3 DK0792165 T3 DK 0792165T3
Authority
DK
Denmark
Prior art keywords
immunogenic preparations
immunogenic composition
immunogenic
preparations
solubilised
Prior art date
Application number
DK95936690T
Other languages
Danish (da)
English (en)
Inventor
Roger Randal Charles New
Original Assignee
Vaxcine Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vaxcine Ltd filed Critical Vaxcine Ltd
Application granted granted Critical
Publication of DK0792165T3 publication Critical patent/DK0792165T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/08—Clostridium, e.g. Clostridium tetani
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK95936690T 1994-11-15 1995-11-14 Immunogene præparater DK0792165T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9422990A GB9422990D0 (en) 1994-11-15 1994-11-15 Immunogenic compositions
PCT/GB1995/002675 WO1996014871A1 (fr) 1994-11-15 1995-11-14 Compositions immunogenes

Publications (1)

Publication Number Publication Date
DK0792165T3 true DK0792165T3 (da) 2004-01-05

Family

ID=10764393

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95936690T DK0792165T3 (da) 1994-11-15 1995-11-14 Immunogene præparater

Country Status (19)

Country Link
EP (1) EP0792165B1 (fr)
JP (1) JP4297515B2 (fr)
KR (1) KR970706848A (fr)
CN (1) CN100346828C (fr)
AT (1) ATE249841T1 (fr)
AU (1) AU700910B2 (fr)
CA (1) CA2205083A1 (fr)
DE (1) DE69531793T2 (fr)
DK (1) DK0792165T3 (fr)
ES (1) ES2210318T3 (fr)
FI (1) FI972054A0 (fr)
GB (1) GB9422990D0 (fr)
IL (1) IL116010A0 (fr)
MX (1) MX9703480A (fr)
NO (1) NO972219L (fr)
NZ (1) NZ295238A (fr)
PT (1) PT792165E (fr)
WO (1) WO1996014871A1 (fr)
ZA (1) ZA959729B (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9323588D0 (en) 1993-11-16 1994-01-05 Cortecs Ltd Hydrophobic preparation
US6165773A (en) * 1995-10-25 2000-12-26 Provalis Uk Limited Methods of preserving viruses
GB9613858D0 (en) 1996-07-02 1996-09-04 Cortecs Ltd Hydrophobic preparations
AR013202A1 (es) * 1997-07-10 2000-12-13 Biotech Australia Pty Ltd Vacunas no acuosas
AU736038C (en) * 1997-07-10 2006-08-10 Intervet Australia Pty Limited Non-aqueous vaccines
US6488936B1 (en) * 1998-02-12 2002-12-03 Wyeth Immunogenic composition of interleukin-12 (IL-12), alum, herpes simplex viral (HSV) antigen, and method thereof
EP1053016A2 (fr) * 1998-02-12 2000-11-22 American Cyanamid Company Vaccins renfermant l'interleukine-12 et antigenes du virus respiratoire syncytial
AU759391B2 (en) * 1998-02-12 2003-04-10 Wyeth Holdings Corporation Pneumococcal and meningococcal vaccines formulated with interleukin-12
ATE375803T1 (de) * 1998-05-07 2007-11-15 Corixa Corp Adjuvanszusammensetzung und methoden zu deren verwendng
US7534443B1 (en) 1998-07-16 2009-05-19 Ichiro Azuma Preparations for immunotherapy for cancer having bacterial somatic constituent as the active ingredient
CN106310293A (zh) 2007-09-27 2017-01-11 免疫疫苗技术有限公司 在包括连续疏水相的载体中的脂质体在体内输送多核苷酸中的应用
CA2700828C (fr) * 2007-10-03 2017-01-24 Immunovaccine Technologies Inc. Compositions comprenant un antigene, un compose amphipathique et un support hydrophobe, et leurs utilisations
AU2009253780B2 (en) 2008-06-05 2014-08-14 Immunovaccine Technologies Inc. Compositions comprising liposomes, an antigen, a polynucleotide and a carrier comprising a continuous phase of a hydrophobic substance
EP2654782A4 (fr) * 2010-12-23 2015-03-25 Immport Therapeutics Inc Procedes et compositions faisant a des antigenes proteiques en vue du diagnostic et du traitement des infections par toxoplasma gondii et de la toxoplasmose
GB201107629D0 (en) * 2011-05-06 2011-06-22 Proxima Concepts Ltd Hydrophobic preparations
CN102277373B (zh) * 2011-08-15 2014-07-02 南京大学 一种减毒沙门氏菌分泌表达的日本血吸虫疫苗表达载体及其应用
EP2763698B1 (fr) 2011-10-06 2020-12-02 ImmunoVaccine Technologies Inc. Compositions liposomales comprenant un adjuvant qui active ou accroît l'activité de tlr2 et utilisations associées

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4578391A (en) * 1982-01-20 1986-03-25 Yamanouchi Pharmaceutical Co., Ltd. Oily compositions of antitumor drugs
IE904098A1 (en) * 1989-11-13 1991-05-22 Nova Pharm Corp Lipospheres for controlled delivery of substances
DK0521562T3 (da) * 1991-06-26 2003-07-14 Yamanouchi Europ Bv Vesikler i ikke-polære medier
DE69418334T2 (de) * 1993-08-06 2000-01-27 Opperbas Holding B.V., Amsterdam Verfahren zur hohen beladung von vesikeln mit biopolymeren substanzen
GB9323588D0 (en) * 1993-11-16 1994-01-05 Cortecs Ltd Hydrophobic preparation

Also Published As

Publication number Publication date
NO972219L (no) 1997-07-11
FI972054A (fi) 1997-05-14
EP0792165B1 (fr) 2003-09-17
IL116010A0 (en) 1996-01-31
FI972054A0 (fi) 1997-05-14
CN1163575A (zh) 1997-10-29
KR970706848A (ko) 1997-12-01
CN100346828C (zh) 2007-11-07
AU3853495A (en) 1996-06-06
DE69531793T2 (de) 2004-07-15
ATE249841T1 (de) 2003-10-15
JP4297515B2 (ja) 2009-07-15
ES2210318T3 (es) 2004-07-01
CA2205083A1 (fr) 1996-05-23
JPH10508834A (ja) 1998-09-02
AU700910B2 (en) 1999-01-14
GB9422990D0 (en) 1995-01-04
EP0792165A1 (fr) 1997-09-03
DE69531793D1 (de) 2003-10-23
WO1996014871A1 (fr) 1996-05-23
ZA959729B (en) 1997-05-15
NO972219D0 (no) 1997-05-14
PT792165E (pt) 2004-02-27
MX9703480A (es) 1997-08-30
NZ295238A (en) 1999-01-28

Similar Documents

Publication Publication Date Title
ATE249841T1 (de) Immunogene zubereitungen
WO1997001640A3 (fr) Vaccins contre l'hepatite c
NO20001768D0 (no) Viruskapsomervaksine, fremgangsmåte til fremstilling samt anvendelse derav
IT1229845B (it) Procedimento per la preparazione di perfluoropolieteri perossidici.
AU2982889A (en) Novel dosage form of fenofibrate
NO912825D0 (no) Fremgangsmaate for fremstilling av cokonjugate vaksiner omfattende immunogenisk protein, hiv-beslektede peptider og anioniske grupper.
AU3799789A (en) Novel benzopyran derivatives, processes for their preparation and their use and preparations containing the compounds
NO892251L (no) Fremgangsmaate ved fremstilling av kokkoidosevaksine ved rekombinante teknikker.
NO872712D0 (no) Fremgangsmaate for fremstilling av kalsiumholdige preparater.
AU7237391A (en) Carrier-bound recombinant protein, process for producing it and its use as an immunogen and vaccine
AU3926097A (en) Improved inactivated vaccines
NO911065D0 (no) Fremgangsmaate for fremstilling av lipopeptidderivater.
FR2748476B1 (fr) Complexe immunogene, son utilisation, son procede de preparation et vaccin le contenant
NO891574D0 (no) Fremgangsmaate for fremstilling av farmasoeytisk anvendbareforbindelser.
AU1825895A (en) Retroviral vaccines, vaccination and immune-therapy for retroviral infections
NO961429D0 (no) Fremgangsmåte for fremstilling av kinolonholdige, orale preparater
NO901892L (no) Fremgangsmaate for fremstilling av (2,1-c)(1,3)-benzodiazepiner og deres anvendelse som medikamenter.
FR2698271B1 (fr) Vaccin contre le virus de la leucémie bovine, nouveau peptide immunogène et kit de vaccination.
RU96116250A (ru) Штамм pestivirus, используемый для изготовления лапинизированной вирус вакцины против классической чумы свиней
NO884921D0 (no) Fremgangsmaate for fremstilling av valpesyke-vaksine.
DK98788D0 (da) Benzylaminoaryl-dihydropyridinlactoner, fremgangmsaade til deres fremstilling samt deres anvendelse som laegemidler
AUPN003194A0 (en) Vaccine for the hiv-1 & hiv-2 virus
ITRM920074A1 (it) Procedimento per la preparazione di vaccini, e vaccini cosi' ottenibili.
IT8884903A0 (it) Catetere per uso medicale.
ATE72439T1 (de) 3-propenylcephemderivate, ihre herstellung, zwischenverbindungen, pharmazeutische praeparate und anwendung.